From Two to One Per Day Calibration of Dexcom G4 Platinum by a Time-Varying Day-Specific Bayesian Prior.

BACKGROUND In the DexCom G4 Platinum (DG4P) continuous glucose monitoring (CGM) sensor, the raw current signal generated by glucose-oxidase is transformed to glucose concentration by a calibration function whose parameters are periodically updated by matching self-monitoring of blood glucose references, usually twice a day, to compensate for sensor variability in time. The aim of this work is to reduce DG4P calibration frequency to once a day by a recently proposed Bayesian calibration algorithm, which employs a time-varying calibration function and suitable day-specific priors. METHODS The database consists of 57 CGM signals that are collected by the DG4P for 7 days. The Bayesian calibration algorithm is used to calibrate the raw current signal following two different schedules, that is, two and one calibration per day. Calibrated glycemic profiles are compared with those originally acquired by the manufacturer, on days 1, 4, and 7, where frequent blood glucose references were available, by using standard metrics, that is, mean absolute relative difference (MARD), percentage of accurate glucose estimates, and percentage of data in the A-zone of Clarke Error Grid. RESULTS The one per day Bayesian calibration algorithm has accuracy similar to that of two per day (11.8% vs. 11.7% MARD, respectively), and it is statistically better (P-value of 0.0411) than the manufacturer calibration algorithm, which requires two calibrations per day (13.1% MARD). CONCLUSIONS A Bayesian calibration algorithm employing a time-varying calibration function and suitable priors enables a reduction of the calibrations of DG4P sensor from two to one per day.

[1]  K. Turksoy,et al.  Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. , 2013, Diabetes technology & therapeutics.

[2]  W. Clarke The original Clarke Error Grid Analysis (EGA). , 2005, Diabetes technology & therapeutics.

[3]  Josep Vehí,et al.  Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices , 2010, Sensors.

[4]  Howard Zisser,et al.  New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. , 2009, Diabetes technology & therapeutics.

[5]  Giovanni Sparacino,et al.  Online Calibration of Glucose Sensors From the Measured Current by a Time-Varying Calibration Function and Bayesian Priors , 2016, IEEE Transactions on Biomedical Engineering.

[6]  Buddy D Ratner,et al.  Biomechanics of the Sensor-Tissue Interface—Effects of Motion, Pressure, and Design on Sensor Performance and the Foreign Body Response—Part I: Theoretical Framework , 2011, Journal of diabetes science and technology.

[7]  Giovanni Sparacino,et al.  Glucose sensors for diabetes management: no need of 24h warm-up time by the use of Bayes estimation , 2015, EMBC 2015.

[8]  T. Bailey,et al.  Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm , 2014, Journal of diabetes science and technology.

[9]  Bruce Buckingham,et al.  Continuous Glucose Monitoring: Current Use and Future Directions , 2013, Current Diabetes Reports.

[10]  R. Bergenstal,et al.  Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. , 2009, Diabetes technology & therapeutics.

[11]  Giovanni Sparacino,et al.  Dexcom G4AP: An Advanced Continuous Glucose Monitor for the Artificial Pancreas , 2013, Journal of diabetes science and technology.

[12]  Giovanni Sparacino,et al.  “Smart” Continuous Glucose Monitoring Sensors: On-Line Signal Processing Issues , 2010, Sensors.

[13]  Thomas Peyser,et al.  A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. , 2013, Diabetes technology & therapeutics.

[14]  Ben Feldman,et al.  Metabolic Biofouling of Glucose Sensors in Vivo: Role of Tissue Microhemorrhages , 2011, Journal of diabetes science and technology.

[15]  I M E Wentholt,et al.  How to assess and compare the accuracy of continuous glucose monitors? , 2008, Diabetes technology & therapeutics.

[16]  5 – Parameter Estimation , 2014 .

[17]  J. Pickup,et al.  Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives , 2014, Diabetes Care.

[18]  R. Rabasa-Lhoret,et al.  Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors. , 2014, Diabetes technology & therapeutics.

[19]  Claudio Cobelli,et al.  Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data. , 2015, Diabetes technology & therapeutics.

[20]  Darrell M. Wilson,et al.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2010 .

[21]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[22]  Linear Time-Invariant Systems [Book Review] , 2004, IEEE Control Systems.

[23]  Allan S. Brett Continuous Glucose Monitoring in Type 1 Diabetes , 2008 .

[24]  Bruce A Buckingham,et al.  Evaluation of factors affecting CGMS calibration. , 2006, Diabetes technology & therapeutics.

[25]  B Wayne Bequette,et al.  Continuous Glucose Monitoring: Real-Time Algorithms for Calibration, Filtering, and Alarms , 2010, Journal of diabetes science and technology.